GlassScriptPhysician profile
Jed R Jularbal
NPI 1780030320
$11,249.26
in general payments reported to CMS, 2019-2025
52 companies · $1,590 in 2025
The $1,590 reported for 2025 was more than what 91% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,859 · 2022: $2,201 · 2023: $1,998 · 2024: $1,602 · 2025: $1,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,189.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,551.18 | 2021-2025 | |
| Novo Nordisk INC | $1,505.89 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Biohaven Pharmaceuticals, INC. | $1,315.70 | 2021 | |
| Lilly USA, LLC | $803.99 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $477.22 | 2021-2025 | Repatha, Otezla, Evenity |
| Corium, LLC | $464.05 | 2022-2024 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $426.78 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $355.77 | 2021-2025 | |
| Pfizer INC. | $334.19 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $309.57 | 2021-2025 | Belsomra, Steglatro, Vaqta |
| Axsome Therapeutics, INC. | $278.44 | 2023-2025 | Auvelity, Symbravo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.95 | 2021-2024 | Jardiance |
| Astellas Pharma US INC | $221.44 | 2021-2025 | Veozah, Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $215.14 | 2021-2023 | Trintellix |
| Amarin Pharma, INC. | $211.54 | 2021 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jed Jularbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.